Delivery Order SPE2DE24D0013-SPE2D626F06EQ
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, a delivery order valued at $3,400 under contract XPRS4PLEX-10 on January 9, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, is a child contract issued without set-aside designation and represents procurement of diagnostic testing supplies for federal healthcare operations. The award falls...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 8, 2025, with an ultimate completion date of December 15, 2025. This delivery order, designated XPRS4PLEX-10, represents a small procurement of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal...
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 delivery order to Cepheid Inc. on January 8, 2026, for molecular diagnostic reagents and test kits under a firm fixed-price structure. This delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 15, 2026, and represents a child order under a larger indefinite delivery contract vehicle. The work will be performed at Cepheid's headquarters in Sunnyvale, California. No set-aside designation was used for this...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $10,200.00 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025. The firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, is designated as XPRS4PLEX-10 and carries no set-aside designation. This delivery order falls under Cepheid's broader contracting relationship with federal healthcare agencies, where...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,530.08 to Cepheid Inc. on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a relatively modest procurement within Cepheid's broader federal contract portfolio. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier. Performance will take place at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,040 on November 17, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems. This firm fixed-price delivery order, designated XPRS4PLEX-10 with completion slated for November 24, 2025, is issued under an existing Indefinite Delivery Contract framework. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an established...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,440 firm fixed-price delivery order to Cepheid Inc. on December 1, 2025, with an ultimate completion date of December 8, 2025. This delivery order, issued under contract number 4570137197, represents a procurement of molecular diagnostic supplies or reagents from Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic testing systems. The award carries no set-aside designation, reflecting Cepheid's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,190.28 to Cepheid Inc. on December 22, 2025, for molecular diagnostic supplies and reagents. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by January 7, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. The delivery order supports the federal healthcare system's diagnostic testing capabilities through Cepheid's GeneXpert...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F06EQDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20.4K to Cepheid Inc. on January 13, 2026, for diagnostic testing supplies and reagents. This delivery order, designated XPRS4PLEX-10, is a child contract under a larger Indefinite Delivery Vehicle and carries a firm fixed-price structure with no set-aside designation. The order is scheduled for completion by January 21, 2026, and will be performed at Cepheid's headquarters location in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic systems, has established itself as a primary federal supplier across multiple defense and civilian healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. This delivery order aligns with Cepheid's core business of supplying rapid molecular diagnostic testing solutions for infectious diseases and clinical conditions, including respiratory pathogens. The company maintains substantial indefinite delivery contracts with the Department of Veterans Affairs, including a $6.7 million single-award contract with VISN 17 and a $32.8 million contract with VISN 6, both extending through 2029-2030. These underlying vehicles enable continuous, demand-driven procurement of diagnostic equipment, reagents, test kits, and maintenance services across the federal healthcare system. Cepheid's extensive federal contracting history and specialized technical expertise in GeneXpert diagnostic platforms position it as a critical supplier supporting clinical laboratory operations and infectious disease testing requirements across multiple federal medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 1/12/26 |